Hsu Brien, Emperumal Chitra Priya, Grbach Vincent X, Padilla Mariela, Enciso Reyes
Master of Science Program in Orofacial Pain and Oral Medicine, Herman Ostrow School of Dentistry of University of Southern California, Los Angeles, California.
Department of Medicine, Keck School of Medicine of University of Southern California, Los Angeles, California.
J Clin Sleep Med. 2020 May 15;16(5):785-801. doi: 10.5664/jcsm.8318. Epub 2020 Feb 6.
The purpose of this study is to conduct a systematic review and meta-analysis evaluating the effects of respiratory muscle therapy (ie, oropharyngeal exercises, speech therapy, breathing exercises, wind musical instruments) compared with control therapy or no treatment in improving apnea-hypopnea index ([AHI] primary outcome), sleepiness, and other polysomnographic outcomes for patients diagnosed with obstructive sleep apnea (OSA).
Only randomized controlled trials with a placebo therapy or no treatment searched using PubMed, EMBASE, Cochrane, and Web of Science up to November 2018 were included, and assessment of risk of bias was completed using the Cochrane Handbook.
Nine studies with 394 adults and children diagnosed with mild to severe OSA were included, all assessed at high risk of bias. Eight of the 9 studies measured AHI and showed a weighted average overall AHI improvement of 39.5% versus baselines after respiratory muscle therapy. Based on our meta-analyses in adult studies, respiratory muscle therapy yielded an improvement in AHI of -7.6 events/h (95% confidence interval [CI] = -11.7 to -3.5; P ≤ .001), apnea index of -4.2 events/h (95% CI = -7.7 to -0.8; P ≤ .016), Epworth Sleepiness Scale of -2.5 of 24 (95% CI= -5.1 to -0.1; P ≤ .066), Pittsburgh Sleep Quality Index of -1.3 of 21 (95% CI= -2.4 to -0.2; P ≤ .026), snoring frequency (P = .044) in intervention groups compared with controls.
This systematic review highlights respiratory muscle therapy as an adjunct management for OSA but further studies are needed due to limitations including the nature and small number of studies, heterogeneity of the interventions, and high risk of bias with low quality of evidence.
本研究旨在进行一项系统评价和荟萃分析,评估呼吸肌治疗(即口咽运动、言语治疗、呼吸练习、吹奏乐器)与对照治疗或不治疗相比,对改善阻塞性睡眠呼吸暂停(OSA)患者的呼吸暂停低通气指数([AHI],主要结局)、嗜睡及其他多导睡眠图结局的效果。
纳入截至2018年11月在PubMed、EMBASE、Cochrane和科学网检索到的仅有的采用安慰剂治疗或不治疗的随机对照试验,并使用Cochrane手册完成偏倚风险评估。
纳入9项研究,共394例诊断为轻至重度OSA的成人和儿童,所有研究评估为高偏倚风险。9项研究中的8项测量了AHI,结果显示呼吸肌治疗后加权平均总体AHI较基线改善了39.5%。基于我们对成人研究的荟萃分析,呼吸肌治疗使AHI改善了-7.6次/小时(95%置信区间[CI]=-11.7至-3.5;P≤.001),呼吸暂停指数改善了-4.2次/小时(95%CI=-7.7至-0.8;P≤.016),爱泼沃斯嗜睡量表评分在24分制中改善了-2.5分(95%CI=-5.1至-0.1;P≤.066),匹兹堡睡眠质量指数在21分制中改善了-1.3分(95%CI=-2.4至-0.2;P≤.026),干预组的打鼾频率(P=.044)与对照组相比有所改善。
本系统评价强调呼吸肌治疗可作为OSA的辅助治疗方法,但由于存在包括研究性质和数量、干预措施的异质性以及证据质量低导致的高偏倚风险等局限性,仍需进一步研究。